Singapore
Download
1 / 15

SINGAPORE - PowerPoint PPT Presentation


  • 354 Views
  • Updated On :

SINGAPORE. The Biopolis of Asia By: Luanne Theseira Commercial Specialist U.S. Commercial Service, Singapore Email: [email protected] Singapore – The Biopolis of Asia. Global Biomedical Services Hub Advancing Human Healthcare. Regional HQ. Product & Process Development.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'SINGAPORE' - Donna


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Singapore l.jpg

SINGAPORE

The Biopolis of Asia

By: Luanne Theseira

Commercial Specialist

U.S. Commercial Service, Singapore

Email: [email protected]


Slide2 l.jpg

Singapore – The Biopolis of Asia

Global Biomedical Services Hub Advancing Human Healthcare

Regional HQ

Product & Process Development

Full-scale Manufacturing

Basic & Clinical Research

Healthcare Delivery

Marketing

Source: EDB Singapore


Slide3 l.jpg

Strong IP Protection

World Intellectual Property Office

Madrid Protocol

Berne Convention

Singapore is signatory to major IPR conventions & treaties

Budapest Treaty

Paris Convention

Trade Related Aspects of IPR (TRIPS)

Patent Cooperation Treaty (PCT)

Nice Agreement

“Singapore has a solid infrastructure, strong government support for the biomedical sciences industry, sound intellectual property protection and excellent opportunities for synergistic local collaborations.” Managing Director, Lilly Systems Biology

Source: EDB Singapore


Slide4 l.jpg

ProcessesBiomedical Sciences Cluster

Medical Technology

Biomarkers

Pharmaceutical Services

Drug Discovery

Bioprocessing

Genomics & Proteomics

Molecular & Cell Biology

Bioengineering & Nanotechnology

Computational Biology

Healthcare Services & Delivery

Stem Cells

Bioimaging

Biotechnology

Source: EDB Singapore


Vision l.jpg
VISION

To develop Singapore as the Healthcare Services Hub in Asia. Already the regional hub for South East Asia.

- Expand from less than 1% in 2000 to 3% by 2012.

=> Represent 1 million foreign patients contributing $2.6 billion of value-add or 1% more to GDP


Singapore healthcare services hub in asia l.jpg
Singapore – Healthcare Services Hub in Asia

  • Recognizes the potential growth in regional demand

  • Asia’s population will expand from 3.2 billion to 5. 6 billion in 2050.

  • Consumer expenditure on healthcare services and healthcare goods is expected to grow to US$188 billion in 2013.


Singapore healthcare system health status and best prospects l.jpg
Singapore – Healthcare System, Health Status and Best Prospects

  • Government Expenditure stands at 0.9% of GDP

    ðlower than any developed country

    ðpopulation is much younger at present

    ð  as population ages, health expenditure will be higher

    Singapore Government is looking at ways to address the problem of rising healthcare costs


Healthcare financing l.jpg
Healthcare Financing Prospects

Singapore has a hybrid healthcare financing framework

Two Key Principles :-

  • Individual Responsibility

  • Community and Govt. support for those in need


Primary healthcare services hospital care l.jpg
Primary Healthcare Services / Hospital Care Prospects

Primary Healthcare

  • 80% of the primary healthcare services is provided by the private practitioners

  • 20% by the Govt polyclinics

    Hospital Care

    • 80% of hospital care provided by public sector

    • 20% by the private sector


Health facts l.jpg
Health Facts Prospects

  • Cancer – Biggest Killer in Singapore

  • Heart Disease –2nd Most Common Cause of death

  • Stroke– 4th Most Common

  • Diabetes Mellitus – 8% of population diabetic, accounts for 8% of all deaths

    AIM => to identify these early and take preventive or corrective steps promptly.


Health sciences authority hsa l.jpg
Health Sciences Authority (HSA) Prospects

SINGAPORE’S EQUIVALENT OF THE FDA

  • Health Products Regulation Group

  • Health Products Bill tabled in Parliament in Jan 2007

  • Adopts a Risk-Based Approach

    => Devices approved for use in the U.S., Europe, Japan and Australia are acceptable


Future challenges l.jpg
Future Challenges Prospects

  • The increasing cost of providing healthcare as a result of advances in medical knowledge and technology

  • Rising expectations and demand for better and more sophisticated health services by a more affluent public

  • Rapidly ageing population


Future plans l.jpg
Future Plans Prospects

  • Health spending to reach US$2 billion a year within the next 5 years.

    => Currently, it is US$1.3 billion per year

  • 2 Plots of Land will go on sale in 2007 for the development of private hospitals

  • Expected to yield an additional 400 beds

    • In the Public Sector, approx. 910 beds will come on stream in 2007


Best prospects opportunities l.jpg
Best Prospects / Opportunities Prospects

  • Cutting-edge medical technology and equipment

  • Health Screening products

  • Point-of-Care Diagnostics

  • Preventive Care

  • Home Care

  • Infection Control Products


Slide15 l.jpg

Useful Websites Prospects


ad